Ulcerative colitis (uc) Trials in Montréal, Canada
Conditions / Ulcerative colitis (uc) / Montréal, Canada
Clinical trials for Ulcerative colitis (uc) investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02065622 | Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT06663605 | Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. | COMPLETED | PHASE1 |
| NCT03801928 | Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease | COMPLETED | — |
| NCT03653026 | A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03006068 | A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06850727 | Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis | RECRUITING | PHASE2 |
| NCT03398135 | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02819635 | A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) | COMPLETED | PHASE2/PHASE3 |
| NCT01848561 | A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) | ACTIVE_NOT_RECRUITING | — |
| NCT03398148 | A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE2/PHASE3 |